izpis_h1_title_alt

Health-related quality of life in dogs treated with electrochemotherapy and/or interleukin-12 gene electrotransfer
ID Milevoj, Nina (Author), ID Tozon, Nataša (Author), ID Ličen, Sabina (Author), ID Lampreht Tratar, Urša (Author), ID Serša, Gregor (Author), ID Čemažar, Maja (Author)

URLURL - Source URL, Visit https://onlinelibrary.wiley.com/doi/epdf/10.1002/vms3.232 This link opens in a new window

Abstract
The aim of this study was to evaluate the owners' perception of health-related qual- ity of life (HRQoL) of dogs after treatment with electrochemotherapy (ECT) alone or combined with interleukin-12 gene electrotransfer (IL-12 GET) and/or surgery. The owners of 44 dogs with histologically different tumours were offered the »Cancer Treatment Form« at least one month after treatment. The owners assessed their dogs’ quality of life (QoL) after treatment as good (mean 7.4) (from 1–very poor to 10–excellent) and the general health compared with the initial diagnosis of cancer as improving (mean 3.9) (from 1–worse to 5–better). The assessment of the current QoL was better within the group of dogs treated with non-invasive treatment (ECT and/ or IL-12 GET only), compared with those that received invasive treatment, where, in addition to ECT and/or IL-12 GET, surgery was performed (p < .05). The owners of dogs that achieved an objective response (OR) to the treatment assessed the QoL as significantly better compared with those whose dogs did not respond to the treat- ment (p < .05). The majority of the owners (86.4%) would opt for the therapy again, regardless of the financial costs. In conclusion, the results of this study demonstrate that the majority of the owners of dogs assessed their dogs’ QoL as good and felt that it improved after the treatment, especially in dogs, treated with non-invasive treatment and in those that responded to the treatment. This supports further use of ECT and IL-12 GET as suitable methods for the treatment of selected tumours in veterinary medicine.

Language:English
Keywords:Dogs, electrochemotherapy, gene electrotransfer, health, interleukin-12
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:Str. 1-9
Numbering:Vol. 6
PID:20.500.12556/RUL-116657 This link opens in a new window
UDC:636.09:602.6/7
ISSN on article:2053-1095
DOI:10.1002/vms3.232 This link opens in a new window
COBISS.SI-ID:4920442 This link opens in a new window
Publication date in RUL:01.06.2020
Views:1279
Downloads:181
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Veterinary medicine and science
Shortened title:Vet. med. sci.
Publisher:J. Wiley & Sons
ISSN:2053-1095
COBISS.SI-ID:525255961 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:01.06.2020

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0003
Name:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Funder:ARRS - Slovenian Research Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Funder:ARRS - Slovenian Research Agency
Project number:J3-6796
Name:Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov

Funder:Other - Other funder or multiple funders
Funding programme:COST Action - European Regional Development Fund
Project number:TD 1104

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back